glucagon has been researched along with HIV-Associated Lipodystrophy Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, O; Dela, F; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Nielsen, JO; Storgaard, H | 1 |
| Andersen, O; Dela, F; Fenger, M; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Storgaard, H | 1 |
| Andersen, O; Andersen, UB; Deacon, CF; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Nielsen, JO | 1 |
| Andersen, O; Deacon, CF; Dela, F; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Pedersen, SB | 1 |
1 trial(s) available for glucagon and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.
Topics: Adipose Tissue; Adult; Alanine; Anthropometry; Blood Glucose; Body Composition; Body Mass Index; C-Peptide; Feedback; Glucagon; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Triglycerides | 2004 |
3 other study(ies) available for glucagon and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells.
Topics: Adult; Alanine; Antiretroviral Therapy, Highly Active; Blood Glucose; Body Composition; Cholesterol, HDL; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; HIV; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin; Islets of Langerhans; Lactic Acid; Liver; Male; Middle Aged; Muscle, Skeletal; Triglycerides; Tritium | 2005 |
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.
Topics: Adult; Analysis of Variance; Antiretroviral Therapy, Highly Active; Antiviral Agents; Area Under Curve; Blood Glucose; Body Composition; C-Peptide; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Intolerance; Glucose Tolerance Test; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Peptide Fragments; Protein Precursors | 2005 |
Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy.
Topics: Adult; Alanine; C-Peptide; Case-Control Studies; Glucagon; Glucose; Glucose Clamp Technique; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Lactates; Male; Middle Aged; Stimulation, Chemical; Triglycerides; Tumor Necrosis Factor-alpha | 2006 |